Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-07-10 4:33 pm Purchase | 13G | VAXCYTE INC PCVX | RA CAPITAL MANAGEMENT L.P. | 5,489,181 10.8% | 5,489,181 (New Position) | View |
| 2020-07-10 4:30 pm Purchase | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 3,436,214 20.4% | 275,000 (+8.70%) | View |
| 2020-07-10 4:24 pm Sale | 13G | VERASTEM, INC. VSTM | RA CAPITAL MANAGEMENT L.P. | 9,129,251 5.6% | -9,475,400 (-50.93%) | View |
| 2020-06-25 5:02 pm Purchase | 13D | FORMA THERAPEUTICS HLDGS INC FMTX | RA CAPITAL MANAGEMENT L.P. | 9,011,651 23.4% | 9,011,651 (New Position) | View |
| 2020-06-10 4:15 pm Purchase | 13G | TG THERAPEUTICS, INC. TGTX | RA CAPITAL MANAGEMENT L.P. | 12,788,457 10.8% | 2,908,134 (+29.43%) | View |
| 2020-04-09 4:56 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | RA CAPITAL MANAGEMENT L.P. | 10,364,658 10.7% | 3,974,757 (+62.20%) | View |
| 2020-03-13 5:19 pm Purchase | 13D | KALA PHARMACEUTICALS INC KALA | RA CAPITAL MANAGEMENT L.P. | 10,874,613 19.9% | 6,337,135 (+139.66%) | View |
| 2020-03-05 4:31 pm Purchase | 13G | VERASTEM, INC. VSTM | RA CAPITAL MANAGEMENT L.P. | 18,604,651 13.5% | 18,604,651 (New Position) | View |
| 2020-02-14 4:34 pm Purchase | 13G | PREVAIL THERAPEUTICS INC PRVL | RA CAPITAL MANAGEMENT L.P. | 3,363,605 9.9% | 3,363,605 (New Position) | View |
| 2020-02-14 4:34 pm Purchase | 13G | RETROPHIN, INC. RTRX | RA CAPITAL MANAGEMENT L.P. | 4,252,453 9.9% | 4,252,453 (New Position) | View |
| 2020-02-14 4:34 pm Sale | 13G | ZOGENIX INC ZGNX | RA CAPITAL MANAGEMENT L.P. | 2,260,751 5.1% | -121,417 (-5.10%) | View |
| 2020-02-14 4:34 pm Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA CAPITAL MANAGEMENT L.P. | 4,185,342 8.8% | 52,900 (+1.28%) | View |
| 2020-02-14 4:34 pm Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | RA CAPITAL MANAGEMENT L.P. | 761,666 5.4% | 761,666 (New Position) | View |
| 2020-02-14 4:34 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | RA CAPITAL MANAGEMENT L.P. | 6,389,901 6.6% | 1,543,968 (+31.86%) | View |
| 2020-02-14 4:34 pm Purchase | 13G | ARVINAS INC ARVN | RA CAPITAL MANAGEMENT L.P. | 3,672,872 9.4% | 534,460 (+17.03%) | View |
| 2020-02-14 4:34 pm Purchase | 13G | ARDELYX INC ARDX | RA CAPITAL MANAGEMENT L.P. | 5,527,088 6.7% | 3,423,558 (+162.75%) | View |
| 2020-02-14 4:34 pm Sale | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | RA CAPITAL MANAGEMENT L.P. | 0 0% | -2,415,458 (Position Closed) | View |
| 2020-02-14 4:34 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | RA CAPITAL MANAGEMENT L.P. | 3,247,005 17.4% | 389,862 (+13.65%) | View |
| 2020-02-14 4:34 pm Purchase | 13G | CHEMOCENTRYX INC CCXI | RA CAPITAL MANAGEMENT L.P. | 3,199,389 5.5% | 3,199,389 (New Position) | View |
| 2020-02-14 4:34 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | RA CAPITAL MANAGEMENT L.P. | 3,646,808 14.9% | 162 (+0.00%) | View |